Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-04-08Clinical Trial Update: A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS) [Phase 2]
Phase 2 study to determine the correct inhaled dose of Amikacin delivered directly to the lungs via the Pulmonary Delivery Device System (PD…
-
CLINICAL_TRIALS trial_result · 2011-03-16Clinical Trial Update: Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS) [NA]
This completed clinical trial evaluated the effect of intrapulmonary recombinant human activated protein C on coagulation and inflammation f…
-
CLINICAL_TRIALS research · 2011-03-07Clinical Trial Update: Anti-inflammatory Pulmonal Therapy of Cystic Fibrosis (CF) Patients With Amitriptyline and Placebo [Phase 2]
A Phase 2 clinical trial is evaluating amitriptyline as an anti-inflammatory treatment in cystic fibrosis patients, with placebo control; cu…
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Prophylactic Efficacy of Relenza Against Influenza A and B
Completed clinical trial results evaluating whether Relenza (zanamivir) can prevent influenza A and B infections.
-
CLINICAL_TRIALS trial_result · 2011-02-15Clinical Trial Update: Prognostic Features for Mortality in Young Adults With Pneumonia
This clinical trial update analyzes prognostic features associated with mortality in young adults with pneumonia. The study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-01-06Clinical Trial Update: Red Cell Distribution Width and Mortality in Adult Pneumonia Patients
Clinical trial update examining whether red blood cell distribution width correlates with mortality in adult pneumonia patients.
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: Therapeutic Zinc in Infant Bacterial Illness [Phase 2, Phase 3]
Update on Phase 2 and Phase 3 trials evaluating zinc as a therapeutic for infant bacterial illnesses, including sepsis and pneumonia, with c…
-
CLINICAL_TRIALS trial_result · 2010-10-28Clinical Trial Update: Urokinase Versus Video-assisted Thoracoscopic to Treat Complicated Parapneumonic Empyema in Childhood [Phase 3]
A Phase 3 clinical trial comparing urokinase with video-assisted thoracoscopic surgery for treating complicated parapneumonic empyema in chi…
-
FDA approval · 2010-10-21FDA Approved: PIPERACILLIN AND TAZOBACTAM — Original Application (Hospira, Inc)
FDA approved Hospira's piperacillin/tazobactam combination under an original ANDA application, providing a generic version of the antibiotic…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil [Phase 3]
Phase 3 study evaluating the 13-valent pneumococcal conjugate vaccine in healthy Brazilian infants has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2010-09-24Clinical Trial Update: Probiotic Enteral Administration in Mechanically Ventilated Patients [Phase 1]
A Phase 1 trial evaluating probiotic enteral administration in mechanically ventilated pneumonia patients has been terminated.
-
FDA approval · 2010-09-20FDA Approved: AMPICILLIN AND SULBACTAM — Original Application (Eugia US LLC)
FDA approved an original ANDA for Ampicillin and Sulbactam by Eugia US LLC, authorizing a generic version of the ampicillin-sulbactam antibi…
-
CLINICAL_TRIALS trial_result · 2010-09-09Clinical Trial Update: Effect of Improved Oral Hygiene to Prevent Pneumonia in Hospitalized Patients [Phase 2]
Phase 2 trial evaluating whether improved oral hygiene can prevent pneumonia in hospitalized patients; results posted after completion.
-
CLINICAL_TRIALS research · 2010-08-24Clinical Trial Update: Genetic Variation and Immune Responses After Injury
A clinical trial update examining how genetic variation influences immune responses after injury, including conditions like sepsis and pneum…
-
CLINICAL_TRIALS other · 2010-08-20Clinical Trial Update: Vibration Response Imaging (VRI) in Children With Acute Respiratory Symptoms
A clinical trial evaluating Vibration Response Imaging (VRI) in children with pneumonia has been suspended.
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: A Study To Examine Serologic Response In Hospitalized Patients Receiving Polyvalent Pneumococcal Vaccine
This completed clinical trial evaluated the serologic (antibody) response in hospitalized patients who received a polyvalent pneumococcal va…
-
CLINICAL_TRIALS trial_result · 2010-07-26Clinical Trial Update: Ceftriaxone Versus Chloramphenicol for Treatment of Severe Pneumonia in Children [Phase 3]
The Phase 3 trial comparing ceftriaxone to chloramphenicol for severe pneumonia in children has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-13Clinical Trial Update: Zambia Integrated Management of Malaria and Pneumonia Study [NA]
This completed trial in Zambia evaluated integrated management of malaria and pneumonia, with results posted in July 2010.
-
CLINICAL_TRIALS research · 2010-06-24Clinical Trial Update: Pathogen Identification of Bacterial Pneumonia Via DNA Detection
A completed clinical trial from Peking University People's Hospital evaluating DNA-based pathogen identification for bacterial pneumonia.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia [Phase 2]
Phase 2 safety and tolerability study of doripenem in patients with abdominal infections or pneumonia completed in 2010.
-
FDA approval · 2010-06-07FDA Approved: CEFUROXIME AXETIL — Original Application (Golden State Medical Supply, Inc.)
FDA approved an original application for cefuroxime axetil from Golden State Medical Supply, Inc. for use as an oral antibiotic (ANDA).
-
CLINICAL_TRIALS research · 2010-05-28Clinical Trial Update: Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From Cerebral Hemorrhage [Phase 2, Phase 3]
Clinical trial update on the effectiveness and safety of rhubarb for patients who have suffered a cerebral hemorrhage in Phase 2/Phase 3. Th…
-
CLINICAL_TRIALS trial_result · 2010-05-28Clinical Trial Update: Effectiveness and Safety of Rhubarb for the Treatment of Patients Who Have Suffered From a Stroke [Phase 2]
A Phase 2 trial evaluating the effectiveness and safety of rhubarb in patients after an acute stroke; pneumonia is listed among conditions.
-
FDA label_change · 2010-04-27FDA Approved: CEFACLOR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Cefaclor by Teva, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2010-03-18Clinical Trial Update: Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia [Phase 3]
Phase 3 clinical trial evaluating Lactobacillus GG for prophylaxis of ventilator-associated pneumonia has been completed.